Joseph S McCracken's Net Worth

$557 Thousand

Estimate Recalculated Apr 23, 2024 03:08PM EST

Who is Joseph S McCracken?

Joseph S McCracken does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kindred Biosciences, Inc., Savara Inc, Nexvet Biopharma plc, and LUMOS PHARMA, INC..

SEC CIK

Joseph S McCracken's CIK is 0001632454

Past Insider Trading and Trends

2015 was Joseph S McCracken's most active year for acquiring shares with 6 total transactions. Joseph S McCracken's most active month to acquire stocks was the month of November. 2015 was Joseph S McCracken's most active year for disposing of shares, totalling 6 transactions. Joseph S McCracken's most active month to dispose stocks was the month of June. 2017 saw Joseph S McCracken paying a total of $248,762.50 for 60,600 shares, this is the most they've acquired in one year. In 2021 Joseph S McCracken cashed out on 197,390 shares for a total of $233,285.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kindred Biosciences, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 27
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Apr 20
Form 3
—
0
—
—
0
No matching records found

Savara Inc (SVRA) Snapshot price: $4.705

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.37%
22.5K
—
—
190.84K
Dec 14
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Dec 14
Form 4
+69.40%
68.97K
$1.45
$99,999.25
168.34K
Mar 15
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
—
—
0
Dec 20
Form 4
+65.99%
39.51K
$1.13
$44,637.28
99.37K
Jul 5
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Dec 17
Form 4
+686.06%
52.25K
$4.75
$248,187.50
59.87K
Jun 7
Form 3
—
0
—
—
0
No matching records found

Nexvet Biopharma plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-16.40K
$6.72
-$110,208.00
0
Jul 31
Form 4
+33.33%
4.1K
$0.13
$512.50
16.4K
Jun 30 - Jul 1
Form 4
+4.24%
500
$0.13
$62.50
12.3K
Mar 31
Form 4
+4.42%
500
$0.13
$62.50
11.8K
Dec 31
Form 4
+4.63%
500
$0.13
$62.50
11.3K
Sep 30
Form 4
—
0
—
—
0
Sep 5
Form 4
+61.19%
4.1K
$0.13
$512.50
10.8K
Jun 30 - Jul 1
Form 4
+8.06%
500
$0.13
$62.50
6.7K
Mar 31
Form 4
+8.77%
500
$0.13
$62.50
6.2K
Dec 31
Form 4
+9.62%
500
$0.13
$62.50
5.7K
Sep 30
Form 4
—
0
—
—
0
Sep 3
Form 4
+36.84%
1.4K
$0.13
$175.00
5.2K
Jun 30
Form 4
+58.33%
1.4K
$0.13
$175.00
3.8K
May 18
Form 3
—
0
—
—
0
No matching records found

LUMOS PHARMA, INC. (LUMO) Snapshot price: $3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 10
Form 4
+34.13%
4K
$5.03
$20,120.00
15.72K
Nov 16
Form 4
+37.07%
3.17K
$8.60
$27,262.00
11.72K
Aug 25
Form 4
—
0
—
—
0
May 5
Form 4
+694.70%
7.47K
$7.55
$56,406.35
8.55K
Aug 11
Form 4
+51.76%
367
—
—
1.08K
May 20
Form 4
∞
709
—
—
709
Apr 3
Form 3
—
0
—
—
0
No matching records found